Healthcare Finance News November 8, 2021
Eight out of 10 enrollees in 2022 are projected to be in PDPs operated by just four firms, the numbers show.
Consolidation among standalone Medicare Part D prescription drug plans was the root cause of a 23% decline in offerings for 2022, according to new findings by the Kaiser Family Foundation.
The average Medicare beneficiary will have a choice of 23 stand-alone prescription drug plans (PDPs) in 2022, seven fewer PDP options than in 2021, the data showed. Although the number of PDP options in 2022 is far lower than the peak in 2007 – when there were 56 such options, on average – there are still numerous standalone drug plan options, according to KFF.
Next year, beneficiaries will also...
Today's Sponsors
Today's Sponsor